Liu Kevin, Enke Thomas, Aadam Aziz
Division of Gastroenterology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Gastroenterol Hepatol (N Y). 2020 Sep;16(9):458-463.
Gastroparesis is a complex syndrome with multiple underlying etiologies and pathophysiologies that can cause significant morbidity for patients. Currently, there are limited effective and durable medical and surgical treatments for patients with gastroparesis. As such, there has been recent innovation and development in minimally invasive endoscopic treatments for gastroparesis. Endoscopic therapies that have been investigated for gastroparesis include enteral feeding tube placement, intrapyloric botulinum toxin injection, transpyloric stenting, gastric peroral endoscopic myotomy, and gastric electrical stimulation. This article aims to assess the effectiveness of current endoscopic therapies, as well as discuss future directions for endoscopic therapies, in the management of gastroparesis.
胃轻瘫是一种复杂的综合征,有多种潜在病因和病理生理机制,可给患者带来严重的发病情况。目前,针对胃轻瘫患者的有效且持久的药物和手术治疗方法有限。因此,近年来胃轻瘫的微创内镜治疗有了创新和发展。已针对胃轻瘫进行研究的内镜治疗方法包括放置肠内喂养管、幽门内注射肉毒杆菌毒素、经幽门支架置入、经口内镜下胃肌切开术以及胃电刺激。本文旨在评估当前内镜治疗方法在胃轻瘫管理中的有效性,并讨论内镜治疗的未来方向。